RA
NVRO

Royce & Associates’s NEVRO CORP. NVRO Stock Holding History

Royce & Associates’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-23,000
Closed -$1.84M – 1229
2018
Q2 		$1.84M Sell
23,000
-13,000
-36% -$1.08M 0.01% 851
2018
Q1 		$3.12M Hold
36,000
– – 0.02% 722
2017
Q4 		$2.48M Buy
36,000
+12,000
+50% +$960K 0.02% 797
2017
Q3 		$2.18M Buy
24,000
+10,000
+71% +$856K 0.01% 810
2017
Q2 		$1.04M Buy
+14,000
New +$1.12M 0.01% 966

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Royce & Associates's NVRO Position: Q3 2018 in Review

Royce & Associates sold out of NEVRO CORP. (NVRO) in Q3 2018, closing a stake of 23,000 shares — an estimated $1.84M sold.

Royce & Associates first reported a position in NVRO in Q2 2017 and held it in 5 quarters. The position peaked at $3.12M in Q1 2018. 171 funds tracked by Wall St. Rank hold NVRO as of Q3 2018.

  • Royce & Associates reported no remaining NEVRO CORP. position as of Q3 2018 after selling out during the quarter.
  • Royce & Associates sold 23,000 NEVRO CORP. shares in Q3 2018, an estimated $1.84M.
  • Royce & Associates first reported a position in NEVRO CORP. in Q2 2017 and held it in 5 quarters.
  • Royce & Associates's NEVRO CORP. position peaked at $3.12M in Q1 2018.
  • 171 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2018.

Based on Royce & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.